Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01635374 · ClinicalTrials.gov registry record · NA
Per-Oral Endoscopic Esophagomyotomy (POEM)
A NA study, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
- 400
- Enrollment target
NCT01635374 is a NA study that has completed, run by Northwestern University. The registered enrollment target is 400 participants.
The verdict
NCT01635374, a NA study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 400 participants
- Enrollment target
Study Summary
Achalasia is an esophageal motility disease that usually requires surgical intervention (esophagomyotomy). Laparoscopic techniques have reduced the morbidity associated with myotomy, but post-op GERD, wound infection, hernia and incisional pain are common. A new NOTES based procedure, per-oral endoscopic esophagomyotomy (POEM), has been developed that eliminates the need for skin incisions. All patients enrolled in this study, will have a thorough pre-op workup (including upper endoscopy, upper GI radiographs, high resolution esophageal manometry) confirming the diagnosis of achalasis at the Northwestern Esophageal Center. In this procedure, performed in the operating room under general anesthesia, a flexible endoscope is passed into the esophagus, a mucosal flap and a submucosal tunnel is created. This tunnel extends onto the stomach. The inner circular muscle layer of the lower esophagus and sphincter (LES) is identified and a myotomy is started 3-4cm distal to the mucosal flap and carried all the way onto the stomach. The mucosal opening is then closed with standard endoscopic clips. Patients will be admitted to the hospital and a gastrograffin esophagram will be performed on post-op day 1 to rule out esophageal leak. All patient will have a 2-3 week post-op appointment Patients with a confirmed diagnosis of achalasia may be offered POEM. The investigators hypothesize that POEM is feasible and safe and can effectively reduce residual LES pressure (as determined by manometry) and improve patients symptoms and quality of life.
Interventions
- PROCEDURE Per-Oral Endoscopic Esophagomyotomy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2010-07 |
| Est. Completion | 2014-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01635374
The ClinicalTrials.gov registry entry for NCT01635374 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Per-Oral Endoscopic Esophagomyotomy is the first listed.
NCT01635374 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01635374 about?
NCT01635374 is a clinical study titled "Per-Oral Endoscopic Esophagomyotomy (POEM)". Achalasia is an esophageal motility disease that usually requires surgical intervention (esophagomyotomy). Laparoscopic techniques have reduced the morbidity associated with myotomy, but post-op GERD, wound infection, hernia and incisional pain are common. A new NOTES based procedure, per-oral endos...
What is the current status of trial NCT01635374?
This trial is currently completed. It is a NA study. The enrollment target is 400 participants. The study started on 2010-07. Estimated completion is 2014-01.
What interventions are being tested in trial NCT01635374?
The interventions under investigation include: Per-Oral Endoscopic Esophagomyotomy (PROCEDURE).
Who is sponsoring clinical trial NCT01635374?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.